Technical Analysis for TELO - Telomir Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 4.25 4.68% 0.19
TELO closed up 4.68 percent on Friday, November 1, 2024, on 46 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 4.68%
Down 3 Days in a Row Weakness 4.68%
20 DMA Resistance Bearish -3.63%
MACD Bearish Signal Line Cross Bearish -3.63%
Wide Bands Range Expansion -3.63%
20 DMA Resistance Bearish -12.37%

   Recent Intraday Alerts

Alert Time
Up 5% about 18 hours ago
Possible NR7 about 18 hours ago
Fell Below Previous Day's Low about 21 hours ago
Up 3% about 24 hours ago
Up 2% about 24 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Stem Cell Chemotherapy Osteoarthritis Small Molecule Interleukin 17

Is TELO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.72
52 Week Low 3.11
Average Volume 130,107
200-Day Moving Average 0.00
50-Day Moving Average 5.41
20-Day Moving Average 4.69
10-Day Moving Average 4.42
Average True Range 0.42
RSI (14) 40.48
ADX 18.68
+DI 17.81
-DI 26.99
Chandelier Exit (Long, 3 ATRs) 4.56
Chandelier Exit (Short, 3 ATRs) 5.30
Upper Bollinger Bands 5.42
Lower Bollinger Band 3.97
Percent B (%b) 0.19
BandWidth 30.74
MACD Line -0.33
MACD Signal Line -0.31
MACD Histogram -0.0213
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.63
Resistance 3 (R3) 4.60 4.45 4.56
Resistance 2 (R2) 4.45 4.35 4.46 4.54
Resistance 1 (R1) 4.35 4.30 4.40 4.38 4.52
Pivot Point 4.20 4.20 4.23 4.21 4.20
Support 1 (S1) 4.10 4.10 4.15 4.13 3.98
Support 2 (S2) 3.95 4.05 3.96 3.96
Support 3 (S3) 3.85 3.95 3.94
Support 4 (S4) 3.88